TrialBMC medicine2023

Analysis of phase III clinical trials in metastatic NSCLC to assess the correlation between QoL results and survival outcomes.

Alberto Servetto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.